Literature DB >> 30370083

Borderline multivessel coronary artery disease assessed by fractional flow reserve-affecting practice?

Jacob Lønborg1, Thomas Engstrøm1.   

Abstract

Entities:  

Year:  2018        PMID： 30370083      PMCID： PMC6186603          DOI： 10.21037/jtd.2018.07.129

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.

Authors:  Nico H J Pijls; William F Fearon; Pim A L Tonino; Uwe Siebert; Fumiaki Ikeno; Bernhard Bornschein; Marcel van't Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2010-05-28       Impact factor: 24.094

Review 2.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 3.  Functional measurement of coronary stenosis.

Authors:  Nico H J Pijls; Jan-Willem E M Sels
Journal:  J Am Coll Cardiol       Date:  2012-03-20       Impact factor: 24.094

4.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Authors:  Nico H J Pijls; Pepijn van Schaardenburgh; Ganesh Manoharan; Eric Boersma; Jan-Willem Bech; Marcel van't Veer; Frits Bär; Jan Hoorntje; Jacques Koolen; William Wijns; Bernard de Bruyne
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

5.  Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.

Authors:  Pieter C Smits; Mohamed Abdel-Wahab; Franz-Josef Neumann; Bianca M Boxma-de Klerk; Ketil Lunde; Carl E Schotborgh; Zsolt Piroth; David Horak; Adrian Wlodarczak; Paul J Ong; Rainer Hambrecht; Oskar Angerås; Gert Richardt; Elmir Omerovic
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

6.  A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.

Authors:  Emanuele Barbato; Gabor G Toth; Nils P Johnson; Nico H J Pijls; William F Fearon; Pim A L Tonino; Nick Curzen; Zsolt Piroth; Gilles Rioufol; Peter Jüni; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2016-11-29       Impact factor: 24.094

7.  Fractional flow reserve-guided PCI for stable coronary artery disease.

Authors:  Bernard De Bruyne; William F Fearon; Nico H J Pijls; Emanuele Barbato; Pim Tonino; Zsolt Piroth; Nikola Jagic; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Andreas Limacher; Eveline Nüesch; Peter Jüni
Journal:  N Engl J Med       Date:  2014-09-01       Impact factor: 91.245

8.  Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study.

Authors:  Cornelis J Botman; Jacques Schonberger; Sjaak Koolen; Olaf Penn; Hilde Botman; Nabil Dib; Eric Eeckhout; Nico Pijls
Journal:  Ann Thorac Surg       Date:  2007-06       Impact factor: 4.330

9.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.

Authors:  N H Pijls; B De Bruyne; K Peels; P H Van Der Voort; H J Bonnier; J J Bartunek J Koolen; J J Koolen
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

10.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.

Authors:  Thomas Engstrøm; Henning Kelbæk; Steffen Helqvist; Dan Eik Høfsten; Lene Kløvgaard; Lene Holmvang; Erik Jørgensen; Frants Pedersen; Kari Saunamäki; Peter Clemmensen; Ole De Backer; Jan Ravkilde; Hans-Henrik Tilsted; Anton Boel Villadsen; Jens Aarøe; Svend Eggert Jensen; Bent Raungaard; Lars Køber
Journal:  Lancet       Date:  2015-08-15       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.